Skip to main content

#156620

Anti-CD134 (OX40) [OX86]

Cat. #156620

Anti-CD134 (OX40) [OX86]

Cat. #: 156620

Unit size: 100 ug

Availability: 10-12 weeks

Target: Murine OX40 (CD134) cell surface antigen expressed only by activated T lymphocytes

Class: Monoclonal

Application: FACS ; IHC

Reactivity: Mouse

Host: Rat

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Medical Research Council; University of Oxford

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD134 (OX40) [OX86]
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Mouse
  • Host: Rat
  • Application: FACS ; IHC
  • Description: OX-86 mAb can be used to examine the distribution of OX-40,CD134, a member of the tumour necrosis factor receptor/nerve growth factor receptor super family.
  • Immunogen: Recombinant mouse OX-40 antigen
  • Myeloma used: NS1
  • Recommended controls: IgG1

Target Details

  • Target: Murine OX40 (CD134) cell surface antigen expressed only by activated T lymphocytes
  • Target background: OX-86 mAb can be used to examine the distribution of OX-40,CD134, a member of the tumour necrosis factor receptor/nerve growth factor receptor super family.

Applications

  • Application: FACS ; IHC

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • N/A

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.